Contribution of the ENT (Ear, Nose, and Throat) Surgeon's Clinical Evaluation to the Contouring of Target Volumes and Organs Eligible for Radiotherapy in Head and Neck Cancers (CONTOUR)

Fondation Ophtalmologique Adolphe de Rothschild

Status: Completed

Conditions: Otolaryngology; Radiotherapy, Conformal (IMRT); Head and Neck Cancer; Radiation Oncologists; Surgeons

Treatments: Other: Systematic consideration of the advice of the ENT surgeon in the determination of the radiotherapy target volumes in head and neck cancers.

Study type: Observational

Funder types: NETWORK

Identifiers

NCT03265873

DBU_2017_13

Details and patient eligibility

About

Radiotherapy (RT), surgery and chemotherapy (CT) are treatments for head and neck cancers, used alone or in combination. Conformal RT with Intensity Modulation (IMRT) is currently the reference technique. IMRT requires a precise definition of the target volumes to be treated and the anatomical structures to be protected from irradiation. Most studies of head and neck cancers published in the literature demonstrate the variability in the contouring of the target volumes between radiotherapists. This may have an impact on dosimetry. To date, no studies have evaluated the impact of the ENT surgeon's evaluation in volumes contouring. The aim of this study is to compare the volumes determined by the radiotherapists alone and those determined jointly by the radiotherapists and the ENT surgeon.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years;
• Cancer of the upper aerodigestive tract (oral cavity, oropharynx, larynx, hypopharynx, rhinopharynx, salivary glands, facial sinuses, orbital cavity, ear);
• Cancer confirmed by histopathological analysis;
• Therapeutic protocol including radiotherapy.

Exclusion criteria

• Any history of radiotherapy of the head and neck
• Synchronous head and neck cancer.